Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)

Prospective Multicenter Asian Observational Study of Oncological and Functional Outcomes After Focal Therapy of Prostate Cancer

This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia

Patients undergoing Focal Cryotherapy, Focal HIFU, Focal IRE, Focal Laser ablation, or other partial gland ablation modalities for prostate cancer will be recruited.

Inclusion Criteria:

• Prostate Adenocarcinoma
• Maximum Gleason score 4+4
• Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion)
• Maximum Prostate Specific Antigen (PSA) level 15 ng/dl
• Maximum clinical stage T2c
• American Society of Anesthesiologist Criteria 2 or less

Exclusion Criteria:

• Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted